European Medicines Agency - Regulatory - Regulation of medicines
Company Name [desc] Country
Naturalia SA Greece
Natu-cur Pharma GmbH Germany
Nassington SA Greece
Nassington Limited Cyprus
Napo Therapeutics S.p.A. Italy
NanoSiliCal Devices Srl Italy
NANOREVIV France
Nanobots Therapeutics S.L. Spain
NaDeNo Nanoscience AS Norway
MyoPax GmbH Germany
MWB Consulting SARL France
MULTI-PHARM CO LTD Cyprus
MS Forschungs- und Projektentwicklungs-gGmbH (MSFP) Germany
MRM Health NV Belgium
Morgan S.r.l. Italy
Moreno II - Produtos de Saude, Lda Portugal
Monopar Therapeutics, SARL France
Molecure Spolka Akcyjna Poland
Moleculin Amsterdam B.V. Netherlands
Modus Therapeutics AB Sweden
Modiblast Pharma GmbH Germany
Moberg Pharma AB Sweden
MNLK Immunotherapeutics Unipessoal Lda Portugal
MLM Pharma Consulting Monika Laskowska-Mirończuk Poland
Mitem Pharma France
MIT Gesundheit GmbH Germany
Miramoon Pharma S.L. Spain
MipSalus ApS Denmark
mioWell s.r.o. Slovakia
Minoryx Therapeutics S.L. Spain
MinervaX ApS Denmark
Mimer Medical AB Sweden
MimeCure BV Netherlands
Mileutis SRL Belgium
Microviable Therapeutics S.L. Spain
Micreos Pharma B.V. Netherlands
MGD Azura Limited Ireland
MF Biotech Germany
MEXBRAIN France
MetrioPharm Deutschland GmbH Germany
 
First | Previous | Page 17 of 40 | Next | Last